You are viewing a single comment's thread from:
RE: Analysis of the “Biosimilar” Pharmaceutical Markets - PART 2
The growth from dividends is quite massive and safe AND reliable under any market conditions! Thanks for supporting, there will be plenty more information and I look forward to hearing your thoughts!